本文已被:浏览 182次 下载 145次
投稿时间:2025-07-09 网络发布日期:2026-01-27
投稿时间:2025-07-09 网络发布日期:2026-01-27
中文摘要: 目的 探究活血化瘀方联合肾素-血管紧张素-醛固酮系统(RAAS)抑制剂对糖尿病肾病(DN)的临床疗效,并观察其对氧化应激相关指标的影响。方法 前瞻性选取2023年6月至2025年3月南京中医药大学附属连云港医院收治的80例DN患者,按随机数字表法分为RAAS抑制组(40例,给予糖尿病基础治疗及RAAS抑制剂治疗)和联合组(40例,在RAAS抑制组基础上给予活血化瘀方)。比较两组临床疗效、中医证候积分、肾功能指标[24 h尿蛋白定量、尿白蛋白/肌酐比值(UACR)、血肌酐(Scr)、血尿素氮(BUN)、肾小球滤过率(GFR)]、氧化应激指标[超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)活性、丙二醛(MDA)]。结果 联合组总有效率高于RAAS抑制组(92.50% vs 75.00%,χ2=4.501,P<0.05)。治疗后,两组主症及次症积分均较治疗前降低,且联合组低于RAAS抑制组(P<0.05)。治疗后,两组24 h尿蛋白定量、UACR、Scr及BUN均较治疗前降低,GFR均较治疗前升高,且联合组24 h尿蛋白定量、UACR、Scr及BUN低于RAAS抑制组,GFR高于RAAS抑制组,差异有统计学意义(P<0.05)。治疗后,两组血清 SOD、GSH-Px 较治疗前升高,MDA 水平较治疗前降低,且联合组SOD、GSH-Px高于RAAS抑制组,MDA低于RAAS抑制组,差异有统计学意义(P<0.05)。结论 活血化瘀方联合RAAS抑制剂治疗DN具有显著临床疗效,可有效改善患者的肾功能,降低氧化应激水平。
中文关键词: 活血化瘀方 肾素-血管紧张素-醛固酮系统抑制剂 氧化应激 肾功能 中医证候积分
Abstract:Objective To investigate the clinical efficacy of Huoxue Huayu Decoction combined with renin-angiotensin-aldosterone system(RAAS)inhibitors in the treatment of diabetic nephropathy(DN),and to observe its impact on oxidative stress-related indicators. Methods Eighty DN patients admitted to Lianyungang Hospital TCM Affiliated to Nanjing University of Chinese Medicine from June 2023 to March 2025 were selected and divided into two groups via random number table:the RAAS inhibitor group(n=40)was riven basic diabetes treatment and RAAS inhibitors,and the combined group(n=40)was given Huoxue Huayu Decoction on top of the treatment for the RAAS inhibitor group.The following indexes were compared between the two groups,including clinical efficacy,TCM syndrome scores,renal function indicators [24-hour urinary protein quantification,urinary albumin/creatinine ratio (UACR),serum creatinine(Scr),blood urea nitrogen(BUN),glomerular filtration rate(GFR)],and oxidative stress indicators[activities of superoxide dismutase(SOD)and glutathione peroxidase(GSH -Px),malondialdehyde(MDA)level].Results The total effective rate of the combined group was higher than that of the RAAS inhibitor group(92.50% vs75.00%,χ2=4.501,P<0.05). After treatment,the scores of primary and secondary syndromes in both groups were lower than those before treatment,and the scores in the Combined group were lower than those in the RAAS inhibitorgroup(P<0.05). After treatment,the 24-hour urinary protein quantification,UACR,Scr,and BUN in both groups decreased compared with pre -treatment,while GFR increased,and the combined group had lower 24-hour urinaryprotein quantification,UACR,Scr,and BUN,and higher GFR than the RAAS inhibitor group,with statistically significant differences(P<0.05). After treatment,the serum SOD and GSH-Px activities in both groups were higher than those before treatment,while the MDA level was lower,and the combined group had higher SOD and GSH-Pxactivities and lower MDA level than the RAAS inhibitor group,with statistically significant differences(P<0.05).Conclusion Huoxue Huayu Decoction combined with RAAS inhibitors has a significant clinical effect in the treatment of DN,which can effectively improve patients renal function and reduce the level of oxidative stress.
keywords: Huoxue Huayu decoction Renin-angiotensin-aldosterone system inhibitor Oxidative stress Renalnfunction Traditional Chinese medicine syndrome score
文章编号: 中图分类号:R587.2 R256 文献标志码:A
基金项目:连云港市科技计划项目(SF2324);连云港市“521工程”科研资助项目(LYG06521202375)
附件
| 作者 | 单位 |
| 王莉 | 南京中医药大学连云港附属医院肾病科, 江苏 连云港 222000 |
| 张华鸣 | 南京中医药大学连云港附属医院肾病科, 江苏 连云港 222000 |
| 徐静 | 南京中医药大学连云港附属医院肾病科, 江苏 连云港 222000 |
| 许善文萱 | 南京中医药大学连云港附属医院肾病科, 江苏 连云港 222000 |
引用文本:
王莉,张华鸣,徐静,等.活血化瘀方联合肾素-血管紧张素-醛固酮系统抑制剂对糖尿病肾病的疗效及对氧化应激指标的影响[J].中国临床研究,2026,39(1):38-41.
王莉,张华鸣,徐静,等.活血化瘀方联合肾素-血管紧张素-醛固酮系统抑制剂对糖尿病肾病的疗效及对氧化应激指标的影响[J].中国临床研究,2026,39(1):38-41.
